Hester Biosciences Ltd

Hester Biosciences is engaged in manufacturing of Poultry vaccines and Large Animal Vaccines and trading of Poultry and Large animal health products.(Source : 201903 Annual Report Page No: 86)

Pros:
Company has good consistent profit growth of 34.51% over 5 years
Company has been maintaining a healthy dividend payout of 24.96%
Cons:
Stock is trading at 8.11 times its book value

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Formulations

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Jun 2018 Mar 2019 Jun 2019
40 52 45
25 35 27
Operating Profit 15 17 18
OPM % 37% 33% 39%
Other Income 1 6 1
Interest 1 2 2
Depreciation 2 4 3
Profit before tax 12 17 13
Tax % 31% 20% 38%
Net Profit 9 10 8
EPS in Rs 9.75 15.87 9.51
Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
42 48 65 69 90 101 123 136 178
24 30 43 44 64 67 82 89 110
Operating Profit 18 19 22 24 25 34 41 47 68
OPM % 43% 39% 34% 36% 28% 34% 33% 35% 38%
Other Income 0 0 0 1 3 1 0 3 7
Interest 3 3 3 6 5 4 4 4 7
Depreciation 4 4 4 5 6 6 7 10 12
Profit before tax 11 12 14 13 18 25 31 36 57
Tax % 32% 37% 37% 31% 26% 23% 26% 36% 28%
Net Profit 8 8 9 9 14 19 24 26 42
EPS in Rs 9.33 8.84 10.54 10.77 15.35 21.73 27.68 30.12 48.86
Dividend Payout % 24% 7% 18% 18% 19% 18% 19% 33% 23%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:%
5 Years:20.99%
3 Years:21.00%
TTM:30.99%
Compounded Profit Growth
10 Years:%
5 Years:34.51%
3 Years:29.03%
TTM:62.60%
Return on Equity
10 Years:%
5 Years:21.16%
3 Years:22.58%
Last Year:26.16%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
5 6 9 9 9 9 9 9 9
Reserves 41 54 59 66 76 93 113 132 169
Borrowings 21 16 32 48 55 59 66 69 90
15 19 24 19 20 25 30 37 32
Total Liabilities 82 95 124 142 161 186 218 246 299
39 39 38 54 60 65 102 110 145
CWIP 0 6 29 21 33 36 21 32 7
Investments 0 0 0 0 0 0 0 0 0
43 50 57 68 68 85 94 104 148
Total Assets 82 95 124 142 161 186 218 246 299

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
5 14 12 9 20 19 35 38 48
-4 -10 -23 -15 -21 -13 -30 -26 -23
-1 -2 10 7 7 -7 2 -11 3
Net Cash Flow 1 2 -1 2 5 -1 6 1 28

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 20% 20% 18% 15% 19% 20% 20% 27%
Debtor Days 115 109 85 75 72 95 79 87 65
Inventory Turnover 1.92 2.21 2.06 2.77 3.20 3.67 3.72 3.93